[Statin Therapy As a Protective Factor Regarding Development of Hypoxic Hepatitis]
Overview
Overview
Journal
Med Klin Intensivmed Notfmed
Specialties
Critical Care
General Medicine
General Medicine
Date
2014 Aug 29
PMID
25164968
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Llacuna L, Fernandez A, von Montfort C, Matias N, Martinez L, Caballero F
. Targeting cholesterol at different levels in the mevalonate pathway protects fatty liver against ischemia-reperfusion injury. J Hepatol. 2010; 54(5):1002-10.
DOI: 10.1016/j.jhep.2010.08.031.
View
2.
Jager B, Drolz A, Michl B, Schellongowski P, Bojic A, Nikfardjam M
. Jaundice increases the rate of complications and one-year mortality in patients with hypoxic hepatitis. Hepatology. 2012; 56(6):2297-304.
DOI: 10.1002/hep.25896.
View
3.
Drolz A, Jager B, Wewalka M, Saxa R, Horvatits T, Roedl K
. Clinical impact of arterial ammonia levels in ICU patients with different liver diseases. Intensive Care Med. 2013; 39(7):1227-37.
DOI: 10.1007/s00134-013-2926-8.
View
4.
Drolz A, Horvatits T, Michl B, Roedl K, Schellongowski P, Holzinger U
. Statin therapy is associated with reduced incidence of hypoxic hepatitis in critically ill patients. J Hepatol. 2014; 60(6):1187-93.
DOI: 10.1016/j.jhep.2014.01.019.
View
5.
Fuhrmann V, Kneidinger N, Herkner H, Heinz G, Nikfardjam M, Bojic A
. Impact of hypoxic hepatitis on mortality in the intensive care unit. Intensive Care Med. 2011; 37(8):1302-10.
DOI: 10.1007/s00134-011-2248-7.
View